NO890607L - Fremgangsmaate for fremstilling av terapeutisk aktive pyridin-derivater. - Google Patents

Fremgangsmaate for fremstilling av terapeutisk aktive pyridin-derivater.

Info

Publication number
NO890607L
NO890607L NO89890607A NO890607A NO890607L NO 890607 L NO890607 L NO 890607L NO 89890607 A NO89890607 A NO 89890607A NO 890607 A NO890607 A NO 890607A NO 890607 L NO890607 L NO 890607L
Authority
NO
Norway
Prior art keywords
procedure
preparation
pyridine derivatives
therapeutic active
active pyridine
Prior art date
Application number
NO89890607A
Other languages
English (en)
Other versions
NO890607D0 (no
NO172491B (no
NO172491C (no
Inventor
Andrew George Brewster
George Robert Brown
Alan Wellington Faull
Michael James Smithers
Reginald Jessup
Original Assignee
Ici Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB888803516A external-priority patent/GB8803516D0/en
Priority claimed from GB888824666A external-priority patent/GB8824666D0/en
Application filed by Ici Plc filed Critical Ici Plc
Publication of NO890607D0 publication Critical patent/NO890607D0/no
Publication of NO890607L publication Critical patent/NO890607L/no
Publication of NO172491B publication Critical patent/NO172491B/no
Publication of NO172491C publication Critical patent/NO172491C/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/08Bronchodilators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pulmonology (AREA)
  • Rheumatology (AREA)
  • Hematology (AREA)
  • Vascular Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO890607A 1988-02-16 1989-02-13 Analogifremgangsmaate for fremstilling av terapeutisk aktive 1,3-dioksan-alkensyre-dervater NO172491C (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB888803516A GB8803516D0 (en) 1988-02-16 1988-02-16 Heterocyclic compounds
GB888824666A GB8824666D0 (en) 1988-10-21 1988-10-21 Pyridine derivatives

Publications (4)

Publication Number Publication Date
NO890607D0 NO890607D0 (no) 1989-02-13
NO890607L true NO890607L (no) 1989-08-17
NO172491B NO172491B (no) 1993-04-19
NO172491C NO172491C (no) 1993-07-28

Family

ID=26293498

Family Applications (1)

Application Number Title Priority Date Filing Date
NO890607A NO172491C (no) 1988-02-16 1989-02-13 Analogifremgangsmaate for fremstilling av terapeutisk aktive 1,3-dioksan-alkensyre-dervater

Country Status (24)

Country Link
US (1) US5166213A (no)
EP (1) EP0329360B1 (no)
JP (1) JP2812697B2 (no)
KR (1) KR0145725B1 (no)
CN (1) CN1040753C (no)
AR (1) AR246965A1 (no)
AT (1) ATE109478T1 (no)
AU (1) AU626534B2 (no)
CA (1) CA1335816C (no)
DE (1) DE68917170T2 (no)
DK (1) DK66989A (no)
ES (1) ES2057104T3 (no)
FI (1) FI93216C (no)
GB (1) GB8901201D0 (no)
HU (1) HU209700B (no)
IE (1) IE63825B1 (no)
IL (1) IL89214A (no)
MY (1) MY103699A (no)
NO (1) NO172491C (no)
NZ (1) NZ227880A (no)
PH (1) PH26227A (no)
PL (1) PL158201B1 (no)
PT (1) PT89703B (no)
ZW (1) ZW1789A1 (no)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8709794D0 (en) * 1987-04-24 1987-05-28 Ici Plc Heterocyclic acids
IE81170B1 (en) * 1988-10-21 2000-05-31 Zeneca Ltd Pyridine derivatives
GB9021571D0 (en) * 1990-10-04 1990-11-21 Ici Plc Heterocyclic acids
CA2637803A1 (en) * 2006-01-18 2007-12-06 Evolva Sa Ppar modulators
EP2124558A4 (en) * 2007-01-18 2010-07-14 Evolva Sa SUBSTITUTED 1, 3-DIOXANES AND THEIR USE
CA2676435C (en) * 2007-01-18 2015-03-24 Evolva Sa Substituted 1,3-dioxanes useful as ppar modulators

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0062238B1 (de) * 1981-03-30 1985-01-30 F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft 1,3-Dioxolan-Derivate, Herstellung dieser Verbindungen, fungizide Mittel, die diese Verbindungen als Wirkstoffe enthalten sowie Verwendung solcher Verbindungen bzw. Mittel zur Bekämpfung von Fungi in der Landwirtschaft und im Gartenbau
GB8310407D0 (en) * 1982-05-12 1983-05-25 Ici Plc 1 3 - dioxan -5- ylalkenoic acids
GB8330094D0 (en) * 1983-11-11 1983-12-21 Ici Plc Diphenyl compounds
GB8330099D0 (en) * 1983-11-11 1983-12-21 Ici Plc Cycloalkane derivatives
GB8330120D0 (en) * 1983-11-11 1983-12-21 Ici Plc Chemical process
US4554011A (en) * 1984-08-24 1985-11-19 Chevron Research Company Herbicidal 2S-(2β,4β,5β)-5-Arylmethoxy-4-substituted 2-alkyl-1,3-dioxane derivatives
DE3685775T2 (de) * 1985-05-10 1993-01-21 Ici Plc Alkenderivate.
GB8511892D0 (en) * 1985-05-10 1985-06-19 Ici Plc Fluoralkane derivatives
GB8511895D0 (en) * 1985-05-10 1985-06-19 Ici Plc Heterocyclic compounds
HU198706B (en) * 1985-05-10 1989-11-28 Ici Plc Process for producing 1,3-dioxan-ethers and pharmaceutical compositions containing them
GB8511891D0 (en) * 1985-05-10 1985-06-19 Ici Plc Alkenoic acids
GB8511890D0 (en) * 1985-05-10 1985-06-19 Ici Plc Benzene derivatives
GB8511894D0 (en) * 1985-05-10 1985-06-19 Ici Plc Phenol derivatives
GB8611174D0 (en) * 1986-05-08 1986-06-18 Ici Plc Amide derivatives
ATE56967T1 (de) * 1985-11-12 1990-10-15 Ici Plc Amidderivate.
GB8531892D0 (en) * 1985-12-30 1986-02-05 Ici Plc Carboxylic acids
GB8626296D0 (en) * 1986-11-04 1986-12-03 Ici Plc Therapeutic agents
GB8626297D0 (en) * 1986-11-04 1986-12-03 Ici Plc Pharmaceutical compositions
GB8709794D0 (en) * 1987-04-24 1987-05-28 Ici Plc Heterocyclic acids
IE81170B1 (en) * 1988-10-21 2000-05-31 Zeneca Ltd Pyridine derivatives

Also Published As

Publication number Publication date
KR0145725B1 (ko) 1998-08-17
HUT54143A (en) 1991-01-28
JPH01249770A (ja) 1989-10-05
FI890678A (fi) 1989-08-17
HU209700B (en) 1994-10-28
ZW1789A1 (en) 1990-03-21
FI890678A0 (fi) 1989-02-13
JP2812697B2 (ja) 1998-10-22
PT89703A (pt) 1989-10-04
DK66989A (da) 1989-08-17
ATE109478T1 (de) 1994-08-15
NZ227880A (en) 1991-10-25
KR890013005A (ko) 1989-09-20
DE68917170D1 (de) 1994-09-08
PH26227A (en) 1992-04-01
NO890607D0 (no) 1989-02-13
EP0329360A3 (en) 1990-09-05
EP0329360A2 (en) 1989-08-23
IE63825B1 (en) 1995-06-14
NO172491B (no) 1993-04-19
NO172491C (no) 1993-07-28
CN1035115A (zh) 1989-08-30
DE68917170T2 (de) 1994-12-15
US5166213A (en) 1992-11-24
CN1040753C (zh) 1998-11-18
EP0329360B1 (en) 1994-08-03
FI93216B (fi) 1994-11-30
AU626534B2 (en) 1992-08-06
GB8901201D0 (en) 1989-03-15
CA1335816C (en) 1995-06-06
PL158201B1 (pl) 1992-08-31
PT89703B (pt) 1994-04-29
AR246965A1 (es) 1994-10-31
IE890392L (en) 1989-08-16
ES2057104T3 (es) 1994-10-16
IL89214A (en) 1994-01-25
DK66989D0 (da) 1989-02-13
MY103699A (en) 1993-08-28
AU2990889A (en) 1989-08-17
FI93216C (fi) 1995-03-10

Similar Documents

Publication Publication Date Title
NO894630D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive kinuklidin-derivater.
NO883974L (no) Fremgangsmaate for fremstilling av terapeutiske aktive tetrahydro-hydroksypyranon-derivater.
NO904694L (no) Fremgangsmaate for fremstilling av terapeutisk aktive imidazolderivater.
NO871266L (no) Fremgangsmaate for fremstilling av terapeutisk aktive kinazolin-derivater.
NO901684L (no) Fremgangsmaate for fremstilling av terapeutisk aktive 3-substituerte-2-oksindol-derivater.
NO870526D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive dikloranilin-derivater.
NO880182D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive 1, 2-dihydro-3h-indazol-3h-indazol-3-on-derivater.
NO874032D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive catecholderivater.
NO883122D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive arylamid-derivater.
NO875488D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive alkansulfonanilid-derivater.
NO166130C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 4-pyridonderivater.
NO862372D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive kinolonderivater.
NO891723L (no) Fremgangsmaate for fremstilling av terapeutisk aktive kinazolin-derivater.
NO884176D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive amidinoderivater.
NO895220L (no) Fremgangsmaate for fremstilling av terapeutisk aktive benzenderivater.
NO884175L (no) Fremgangsmaate for fremstilling av terapeutiske aktive heterocykliske derivater.
NO167802C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzotiazepinderivater.
NO864101D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive dikloranilinderivater.
NO890607D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive pyridin-derivater.
NO900972D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive naftalen-derivater.
NO871907D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive alkenamid-derivater.
NO900942D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive azacyklooktadien-derivater.
NO890724D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive tetraazaacenaftylen-derivater.
NO852563L (no) Fremgangsmaate for fremstilling av terapeutisk aktive pyridinderivater.
NO882201L (no) Fremgangsmaate for fremstilling av terapeutisk aktive pyridinderivater.